MAPK3 Human

Mitogen-Activated Protein Kinase 3 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Definition and Basic Characteristics

MAPK3 (mitogen-activated protein kinase 3), also known as ERK1 (extracellular signal-regulated kinase 1), is a serine/threonine kinase encoded by the MAPK3 gene in humans. It plays a central role in the MAPK/ERK signaling cascade, regulating cellular processes such as proliferation, differentiation, and survival .

Key Features:

AttributeDescription
Gene LocationChromosome 16p11.2 (30,114,105–30,123,309 bp)
Protein Length379 amino acids (42.4 kDa)
OrthologsCaenorhabditis elegans (mpk-1), Drosophila melanogaster (rl), Mus musculus (Mapk3)

Functional Role in Cellular Pathways

MAPK3 is activated via phosphorylation by upstream kinases (e.g., MEK1/2) in response to extracellular signals (growth factors, hormones). It translocates to the nucleus, phosphorylating transcription factors like Elk-1, c-Fos, and c-Jun to regulate gene expression .

Core Pathways:

  • Ras-Raf-MEK-ERK Cascade: Mediates mitogenic signals .

  • Apoptotic Regulation: Interacts with Bcl-2 family proteins .

  • Neurotransmitter Signaling: Modulates synaptic plasticity and axon guidance .

Table 1: MAPK3 Interactions

Partner ProteinInteraction TypeFunctional Impact
DUSP3/DUSP6Phosphatase bindingRegulates MAPK3 dephosphorylation
MAP2K1/MAP2K2Kinase activationUpstream activation via MEK1/2
TP53, MYC, RPS6KA2Transcriptional controlModulates cell cycle and apoptosis

Clinical Significance and Disease Associations

MAPK3 dysregulation is implicated in oncogenesis, neurodevelopmental disorders, and ischemic injuries.

Cancer

  • Lung Adenocarcinoma: High MAPK3 mRNA/protein expression correlates with favorable survival (p < 0.01) .

  • Glioma: Elevated MK3 (MAPK3) levels associate with poor prognosis and advanced tumor grades .

Table 2: MAPK3 in Cancer

Cancer TypeExpression PatternPrognostic ImpactReference
Lung adenocarcinomaHigh expressionImproved survival
GliomaHigh expressionPoor prognosis

Neurological Disorders

  • Autism Spectrum Disorder (ASD): MAPK3 resides in the 16p11.2 microdeletion locus, linked to ASD . Missense variants disrupt synaptic targeting .

  • Cerebral Ischemia: Phosphorylated MAPK3 exacerbates ferroptosis, worsening neurological outcomes .

Ovulation Regulation

Pharmacological inhibition of MAPK3/1 (e.g., PD0325901) blocks LH-induced ovulation in mice, suggesting its role in follicular development .

Ferroptosis and Ischemia

In hypoxic-reperfused cells, MAPK3 phosphorylation correlates with reduced GPX4/FTH1 (ferroptosis suppressors) and increased TFR1 (ferroptosis inducer) .

Table 3: MAPK3 in Ferroptosis

ModelMAPK3 RoleFerroptosis MarkersOutcome
SY5Y OGD/R cellsPhosphorylated form ↑GPX4 ↓, FTH1 ↓, TFR1 ↑Increased neuronal damage
Cardiac arrest patientsLow expressionPredicts better neurological recovery

Genetic and Epigenetic Regulation

  • MicroRNAs: Influenza A virus infection downregulates MAPK3 via miRNA activation .

  • Epigenetics: MAPK3 expression is linked to H3K27ac and RPB2 chromatin peaks in schizophrenia .

Table 4: Regulatory Mechanisms

MechanismEffectContext
miRNA activationMAPK3 suppressionViral infection
H3K27ac enrichmentMAPK3 upregulationSchizophrenia

Product Specs

Introduction
Extracellular signal-regulated kinases (ERKs), also known as classical MAP kinases, are intracellular signaling molecules that play a crucial role in various cellular processes, including cell division, differentiation, and response to external stimuli. These protein kinases are activated by a diverse range of signals, including growth factors, cytokines, and environmental stresses. Upon activation, ERKs initiate signaling cascades that ultimately lead to changes in gene expression and cellular behavior. The ERK pathway is a critical regulator of cell growth and survival, and its dysregulation is implicated in various diseases, including cancer.
Description
ERK1/MAPK3 Recombinant is an active form of the ERK1/MAPK3 protein, produced by in vitro phosphorylation using MEK1. It is a non-glycosylated polypeptide with a molecular weight of 43.6 kDa. This recombinant protein is purified using proprietary chromatographic techniques to ensure high purity and activity.
Physical Appearance
Clear solution, sterile-filtered.
Formulation
ERK1 is supplied in a buffer solution containing 50mM Tris-HCl (pH 8.0), 150mM NaCl, 2mM DTT, and 5mM EDTA.
Unit Definition
The specific activity of the enzyme is measured as the amount of phosphate transferred from ATP to myelin basic protein per minute per milligram of protein at 30°C. One unit (U) is defined as the amount of enzyme that catalyzes the transfer of 1 picomole of phosphate per minute. The enzyme has a specific activity greater than 200 U/mg and is free from detectable protease activity.
Stability

For short-term storage (2-4 weeks), the product can be stored at 4°C. For long-term storage, it is recommended to store the product in aliquots at -20°C. Repeated freezing and thawing should be avoided to maintain product stability.

Purity
The purity of the protein is determined by SDS-PAGE and is greater than 95%.
Synonyms
Mitogen-activated protein kinase 3, EC 2.7.11.24, Extracellular signal-regulated kinase 1, ERK-1, Insulin-stimulated MAP2 kinase, MAP kinase 1, MAPK 1, p44-ERK1, ERT2, p44-MAPK, Microtubule-associated protein 2 kinase, ERK1, PRKM3, P44ERK1, P44MAPK, HS44KDAP, HUMKER1A, MGC20180.
Source
Escherichia Coli.

Q&A

What is MAPK3 and what are its alternative names?

MAPK3, also known as ERK1 (Extracellular Signal-Regulated Kinase 1), p44mapk, p44erk1, and PRKM3, is a mitogen-activated protein kinase involved in stress response signaling and potentially cell cycle control. This serine/threonine kinase plays a crucial role in cellular signal transduction pathways . When conducting literature searches or designing experiments, researchers should be aware of all nomenclature variations to ensure comprehensive coverage of relevant studies. MAPK3 must be distinguished from its closely related paralog MAPK1 (ERK2), as they share significant structural and functional similarities despite being encoded by different genes.

Where is MAPK3 located in the human genome?

MAPK3 is located on chromosome 16 at cytogenetic band 16p11.2. The gene spans from base pair 30,114,105 to 30,123,309 on the minus strand . This genomic location information is essential for researchers designing genetic studies, including CRISPR/Cas9 genome editing approaches, genetic association studies, or primers for gene expression analysis. When working with this genomic region, researchers should consider:

  • The presence of known polymorphisms that might affect function or expression

  • The orientation on the minus strand, which has implications for transcriptional studies

  • Potential copy number variations in this region that may affect MAPK3 dosage

What are the main cellular functions and localizations of MAPK3?

MAPK3 participates in numerous cellular processes as evidenced by its extensive Gene Ontology annotations. Key functions include:

  • MAPK cascade signaling

  • Activation and regulation of MAPK activity

  • Protein phosphorylation and its regulation

  • Apoptotic processes

  • DNA damage-induced protein phosphorylation

  • Cell cycle regulation

  • Axon guidance

MAPK3 exhibits a dynamic subcellular distribution across multiple cellular compartments including:

  • Nucleus and nuclear envelope

  • Nucleoplasm

  • Mitochondrion

  • Early and late endosomes

  • Golgi apparatus

  • Cytosol

  • Cytoskeleton

  • Caveolae

  • Focal adhesions

This diverse localization reflects the multiple functions of MAPK3 and its involvement in signal transduction across various cellular compartments.

How does MAPK3 fit into the broader MAPK signaling network?

MAPK3 functions within a three-tiered kinase cascade that characterizes MAPK signaling networks. In this hierarchy, MAP3Ks (MAPK kinase kinases) phosphorylate and activate MAP2Ks (MAPK kinases), which then phosphorylate and activate MAPKs like MAPK3 .

The human MAPK network consists of 24 MAP3Ks, 7 MAP2Ks, and 14 MAPKs . Among the 14 MAPKs, three major groups are identified based on sequence homology, functional redundancy, and shared activation mechanisms:

  • The ERKs (including MAPK3/ERK1)

  • The p38s (α,β,δ,γ)

  • The JNKs (1/2/3)

While MAPK pathways are often depicted as linear cascades, research has revealed extensive crosstalk and feedback regulation, suggesting that the system operates as a network rather than isolated pathways . This complexity has significant implications for experimental design and interpretation.

What methodologies are most effective for studying MAPK3 activation in live cells?

Studying MAPK3 activation in live cells requires techniques that can capture the dynamic, spatiotemporal aspects of kinase activity. Current state-of-the-art approaches include:

Multiplexed MAPK Activity Biosensors:
Advanced biosensor systems allow simultaneous monitoring of multiple MAPK pathways (ERK, JNK, p38) in the same cell, enabling researchers to study network-level responses and pathway crosstalk . These FRET-based systems provide real-time visualization of MAPK3 activity and are particularly valuable for understanding how MAPK3 works within the context of the broader MAPK network.

Experimental Design Considerations:

  • Selection of appropriate biosensor designs with optimal dynamic range

  • Maintaining physiological expression levels to avoid artifacts

  • High-quality microscopy with appropriate temporal resolution

  • Robust image analysis pipelines for quantifying activity

  • Appropriate controls for photobleaching and phototoxicity

This approach has revealed that many stimuli activate multiple MAPK pathways simultaneously but with distinct temporal patterns that can be correlated with specific cellular outcomes .

How do different combinations of MAPK activity determine cell fate decisions?

Research using multiplexed MAPK biosensors has revealed that specific combinations of MAPK activities, rather than individual pathway activation, often determine cell fate decisions . These activity combinations are typically controlled by specific MAP3Ks:

MAP3K FamilyMAPK Activation PatternAssociated Cell Fate
RAFsPreferentially activate ERKProliferation/Differentiation
ASKsActivate p38Stress response/Apoptosis
MLKsActivate ERK and JNKProliferation
MEKKsActivate all three (ERK, JNK, p38)Context-dependent
ZAK and TAKActivate JNK and p38Stress response
COTActivate ERK and p38Mixed response

Experimental evidence shows that cells entering the cell cycle in response to growth factors (EGF) or G-protein coupled receptor agonists (S1P) display significantly higher MLK-driven JNK signaling . Blocking either ERK or JNK with specific inhibitors abolishes the proliferative effects of these stimuli, demonstrating that the combination of ERK+JNK activity is required for this cellular outcome .

This research highlights the importance of studying MAPK3 in the context of the entire MAPK network rather than in isolation.

What challenges exist in determining MAPK3 specificity within signaling networks?

Several significant challenges complicate the study of MAPK3 specificity:

Network Complexity:
The extensive interconnections within the MAPK network (24 MAP3Ks, 7 MAP2Ks, 14 MAPKs) make it difficult to isolate the specific role of MAPK3 . Many stimuli activate multiple MAPK pathways simultaneously but with quantitatively distinct temporal patterns.

Temporal Dynamics:
MAPK3 activation exhibits complex temporal patterns (transient, sustained, oscillatory) that can determine different cellular outcomes. Single cell analysis has revealed both digital and analogue signaling modes depending on the stimuli and the MAPK pathway .

Context Dependence:
The function of MAPK3 can vary dramatically depending on cell type, developmental stage, and concurrent signaling events. For example, the dual functional role of JNK activity (either promoting proliferation or apoptosis) depends on context and potentially on the temporal patterns of activation .

Methodological Approaches to Address These Challenges:

  • Systematic perturbation using chemical inhibitors and genetic ablation of specific MAP3Ks

  • Multiplexed activity biosensors to monitor multiple MAPK pathways simultaneously

  • Single-cell approaches to account for cellular heterogeneity

  • Controlled overexpression systems to isolate the output of individual MAP3Ks

How can researchers investigate the role of MAPK3 in aging processes?

Methodological Approaches:

  • Age-series comparisons of MAPK3 expression and activity across different tissues

  • MAPK3-null mouse models to study long-term effects on lifespan and healthspan

  • Analysis of MAPK3 activity in response to age-related stressors

  • Investigation of changes in MAPK3 localization or post-translational modifications during aging

  • Integration with other aging-related signaling pathways

Key Considerations for Aging Research:

  • Tissue-specific effects of MAPK3 signaling

  • Sex-specific differences in MAPK3 function during aging

  • Potential compensatory mechanisms in genetic models

  • Translation between murine models and human aging processes

Research has shown that MAPK3-null mice are viable and fertile but have defective thymocyte maturation, suggesting a role in immune system development and potentially immunosenescence .

What are the most effective approaches for studying MAP3K-MAPK specificity?

Understanding the specificity of MAP3K-MAPK interactions is crucial for unraveling the complex regulation of MAPK3. Several complementary approaches have proven effective:

Systematic Genetic and Chemical Perturbations:

  • CRISPR knockout of non-redundant MAP3Ks (such as COT, TAK, and ZAK)

  • Small molecule inhibitors for redundant groups of MAP3K activities (MLKs, RAFs, MEKKs, ASKs)

  • Combined with multiplexed MAPK activity monitoring to determine the resulting MAPK activation patterns

MAP3K Overexpression Systems:

  • Generation of stable cell lines capable of overexpressing individual MAP3Ks while reporting ERK, JNK, and p38 activity

  • Allows identification of the specific MAPK activation patterns triggered by each MAP3K

  • Real-time analysis ensures recording at minimal overexpression levels to reduce off-target effects

This systematic approach has revealed that overexpression of individual MAP3Ks triggers unique combinations of MAPK activities that are preserved within phylogenetically related kinases . These patterns correlate well with the signaling patterns elicited by natural stimulation, supporting the physiological relevance of the approach.

How can researchers differentiate between the effects of MAPK3 and related MAPK proteins?

Distinguishing the specific functions of MAPK3 (ERK1) from closely related proteins, particularly MAPK1 (ERK2), presents a significant challenge due to their structural and functional similarities.

Methodological Approaches:

  • Isoform-specific genetic knockdown or knockout using carefully designed CRISPR/siRNA targeting unique regions

  • Rescue experiments with wild-type or mutant MAPK3 in knockout backgrounds

  • Isoform-specific antibodies for immunoprecipitation and Western blotting

  • Carefully titrated doses of inhibitors that show preferential effects on specific isoforms

  • Phosphoproteomic analysis to identify isoform-specific substrates

Experimental Considerations:

  • Controlling for compensatory mechanisms when one isoform is eliminated

  • Cell type-specific differences in the relative importance of MAPK3 versus related MAPKs

  • Validation across multiple experimental systems and techniques

  • Careful quantification of the relative expression levels of different MAPK isoforms

What are the best experimental stimuli for activating MAPK3 in research studies?

Various stimuli have been used to activate MAPK pathways in experimental settings, each activating specific combinations of MAP3Ks and downstream MAPKs:

StimulusTypeMAPK Activation PatternPrimary MAP3K Mediator
H₂O₂Oxidative stressMultiple MAPKsASK1
AnisomycinRibotoxic stressJNK and p38ZAK
EGFGrowth factorERK (primary), others (secondary)RAF and MLK
S1PGPCR agonistMultiple MAPKsMultiple MAP3Ks
IL1β/TNFαCytokinesJNK and p38TAK and COT

Experimental evidence shows that these diverse environmental perturbations all elicit activation of more than one MAPK but with quantitatively distinct temporal patterns . When selecting stimuli for MAPK3 research, consideration should be given to:

  • Concentration optimization to maximize MAPK response while minimizing cell death

  • Temporal analysis to capture both immediate and delayed responses

  • Single-cell monitoring to account for heterogeneity in responses

  • Use of appropriate inhibitors to confirm pathway specificity

How might MAPK3 research contribute to understanding disease mechanisms?

MAPK3, as part of the ERK signaling pathway, is implicated in numerous diseases including cancer, immune disorders, and neuropathies . Understanding the precise role of MAPK3 in these contexts requires integration of basic research findings with disease-specific investigations.

Key Research Approaches:

  • Analysis of MAPK3 mutations, copy number variations, or expression changes in disease tissues

  • Correlation of MAPK3 activity patterns with disease progression or treatment response

  • Development of disease-relevant cellular and animal models with modified MAPK3 function

  • Integration of MAPK3 research with studies of related signaling pathways implicated in disease

Emerging Areas of Interest:

  • The role of MAPK3 in cancer cell resistance to targeted therapies

  • MAPK3 function in neurodegeneration and potential neuroprotective strategies

  • Immune system dysregulation through altered MAPK3 signaling

  • Metabolic disorders and the influence of MAPK3 on metabolic pathways

What technological advances are changing how researchers study MAPK3?

Several emerging technologies are transforming MAPK3 research:

Advanced Biosensor Technologies:

  • Improved FRET biosensors with greater sensitivity and dynamic range

  • Optogenetic tools for precise spatial and temporal control of MAPK3 activity

  • Single-molecule imaging to track individual MAPK3 molecules within cells

  • Nanoparticle-based sensors for in vivo MAPK3 activity monitoring

Systems Biology Approaches:

  • Multi-omics integration (transcriptomics, proteomics, phosphoproteomics)

  • Network inference algorithms to map MAPK3 interactions

  • Machine learning for predicting MAPK3 activity from cellular phenotypes

  • Mathematical modeling of MAPK network dynamics

Genome Engineering:

  • CRISPR interference/activation for precise modulation of MAPK3 expression

  • Base and prime editing for introducing specific MAPK3 mutations

  • Tissue-specific and inducible MAPK3 modification systems

  • Humanized model organisms for more translational MAPK3 research

These technological advances offer unprecedented opportunities to understand MAPK3 function within complex signaling networks and diverse cellular contexts.

Product Science Overview

Gene and Protein Structure

MAPK3 is a protein-coding gene located on chromosome 16 in humans. The gene encodes a serine/threonine kinase, which is activated by upstream kinases. Upon activation, MAPK3 translocates to the nucleus, where it phosphorylates nuclear targets . The protein is composed of 379 amino acids and has a molecular weight of approximately 44 kDa .

Function and Mechanism

MAPK3, along with MAPK1 (ERK2), forms part of the MAPK/ERK cascade. This cascade is initiated by various extracellular signals, such as growth factors, cytokines, and environmental stresses. The activation of MAPK3 involves a series of phosphorylation events, leading to its translocation to the nucleus. Once in the nucleus, MAPK3 phosphorylates various transcription factors, thereby regulating gene expression .

Biological Significance

The MAPK/ERK pathway, in which MAPK3 plays a pivotal role, is essential for numerous cellular functions. These include:

  • Cell Proliferation: MAPK3 promotes cell division by regulating the expression of genes involved in the cell cycle.
  • Differentiation: It influences the differentiation of various cell types by modulating specific transcription factors.
  • Survival and Apoptosis: MAPK3 can either promote cell survival or induce apoptosis, depending on the cellular context and the nature of the extracellular signals .
Clinical Relevance

Mutations or dysregulation of MAPK3 have been associated with several diseases, including:

  • Autism Spectrum Disorder: Alterations in MAPK3 signaling have been linked to neurodevelopmental disorders .
  • Epilepsy: Abnormal MAPK3 activity has been implicated in the pathogenesis of epilepsy .
Research and Therapeutic Potential

Given its central role in critical cellular processes, MAPK3 is a target of interest in various therapeutic strategies. Inhibitors of the MAPK/ERK pathway are being explored for their potential in treating cancers and other diseases characterized by aberrant MAPK3 signaling .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.